A new CSP position was established today on Abbott Laboratories (ABT). All prices include IB commissions.
This is the third position on ABT.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Champion |
| Years of Consecutive Dividend Increases | 38 |
| Years of Positive Free Cash Flow (last 10 years) | 10 |
| Ratio of P/E at Cost / 5yr Average P/E | 0.64 |
| Discount to Morningstar's Fair Value Estimate | 35.29% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 2/8/2011 | ABT | CSP Margin Used | CSP 100 ABT @ 44.00 | ($4,400.00) | ||
| 2/8/2011 | ABT | Initial Put Option | STO 1 Mar11 44.00 Put @ 0.34 | $33.99 |
Position Summary
| Cost Basis | ($4,400.00) |
| Income Generated | $33.99 |
| Percent Income Generated | 0.77% |
| Annualized Income Generated | 7.42% |
| Net Profit If Assigned | $33.99 |
| Percent Return If Assigned | 0.77% |
| Annualized Return If Assigned | 7.42% |
| Days Held to Expiration | 38 days |
